Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any new supplement or wellness protocol.
Home/ Articles/ Semaglutide Explained: The Science Behind the Weight Loss Peptide
weight-management

Semaglutide Explained: The Science Behind the Weight Loss Peptide

How does semaglutide work for weight loss? The GLP-1 science, clinical trial results, side effects, and what to know before considering it.

semaglutidesemaglutide for weight lossGLP-1 agonisthow does semaglutide worksemaglutide side effectstirzepatide
WellSourced Editorial ·Published April 12, 2026 ·Reviewed May 10, 2026 ·15 min read
Semaglutide Explained: The Science Behind the Weight Loss Peptide
The Well-Sourced Take
  • Semaglutide has some of the strongest clinical trial data of any weight-loss intervention — multiple large randomized controlled trials support its efficacy.
  • It works by mimicking GLP-1, a gut hormone that reduces appetite and slows digestion — not a stimulant or fat burner.
  • Side effects are real and common: nausea, GI distress, and rare but serious risks including pancreatitis.
  • Tirzepatide (Mounjaro) adds GIP receptor action and shows slightly stronger weight loss in head-to-head data.
  • Best for: People who want the clinical science behind semaglutide explained clearly before discussing it with a prescriber.

Semaglutide is everywhere — headlines, social feeds, waiting rooms. But how does it actually work? And what do the clinical numbers really mean when you look past the before-and-after photos?

Semaglutide is a GLP-1 receptor agonist. The STEP trials showed 15–17% average body weight loss over 68 weeks. The SELECT trial showed a 20% reduction in major cardiovascular events. The mechanism is real. The results are real. The conversation starts with a doctor.

For the complete breakdown including mechanism, side effect management, and what tirzepatide changed: Understanding Semaglutide: Beyond the Weight Loss Headlines →

Related Reading

Share Twitter / X LinkedIn
Related Reading

Well Noted

Stay Well Noted

Weekly peptide intel, longevity research, and wellness insights — free, every Friday.

Learn about Well Noted →